ARCHIVES

FDA cancer therapeutics review split among three units in reorganization.

This article is from The Cancer Letter archive.

Vol. 29 No. 37 | October 10, 2003

Download PDF Visit The Full Archive

Related Articles

NCI spends A Third Of Its Budget On Prevention

May 15, 1992

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

November 23, 1979

Survey Show Better Understanding Of Breast Cancer

December 12, 1980

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

Three Nurse Awards Made In Self Care

September 30, 1988

ACS: Decline in Death Rates Saved Over 1.3 Million Lives

January 10, 2014